Published

Can psychedelic drug help with depression?

No abstract is available for this record.

Open source BibTeX RIS

Bibliographic context

Journal: The New Scientist
Date: 2018-01-31
Source: OpenAlex
DOI: 10.1016/s0262-4079(18)30332-4
PubMed: Unavailable

Authors

Jessica Hamzelou

Watch author

Topics and keywords

psilocybin Depression Anxiety Other Psilocybin Hallucinogen Depression (economics)Anxiety Psychiatry Psychology MAGIC (telescope)Physics Quantum mechanics Economics Macroeconomics Psychedelics and Drug Studies Digital Mental Health Interventions Mental Health Research Topics

Citation graph

0 referenced DOIs found in stored source metadata. 1 indexed paper cite this DOI.

Open citation network

Indexed papers citing this DOI

Can psychedelic drug help with depression?2018-01-31

Related papers

Psilocybin-induced neurocardiogenic syncope: a case reportPsychopharmacology · 2026-05-27 A phase 1 study of a second experience with Group Retreat Psilocybin Therapy for partial responders after a first experienceFrontiers in Public Health · 2026-04-13 Therapeutic Potential of Psilocybin in Psychiatric Disorders: Mechanisms, Efficacy, and Clinical ImplicationsFOCUS The Journal of Lifelong Learning in Psychiatry · 2026-03-31 Psychedelic Therapies for Comorbid Major Depressive Disorder and Chronic Pain: A Review of Putative Mechanisms of ActionPharmacology Research & Perspectives · 2026-03-31 PSILOCYBIN AS AN ADJUNCTIVE TREATMENT FOR DEPRESSION AND PSYCHOLOGICAL DISTRESS IN ONCOLOGY: CURRENT EVIDENCE AND CLINICAL IMPLICATIONSInternational Journal of Innovative Technologies in Social Science · 2026-03-18 Hallucinogens for Mood and Anxiety Disorders: A Critical Review of Psychedelic-Assisted TherapiesThinkIR: The University of Louisville's Institutional Repository (University of Louisville) · 2026-03-15 Editorial: Psychedelic substances and neurological diseases: from basics to clinical applicationFrontiers in Pharmacology · 2026-03-15 Advancing cancer neuroscience through stress modulation: Interdisciplinary potential of psilocybin and ketamineGeneral Hospital Psychiatry · 2026-02-24